Back to BALYASNY ASSET MANAGEMENT L.P. BALYASNY ASSET MANAGEMENT L.P.

RLMDRLMD
8 quarters

Position history for BALYASNY ASSET MANAGEMENT L.P.BALYASNY ASSET MANAGEMENT L.P.'s holdings in RELMADA THERAPEUTICS INC

BALYASNY ASSET MANAGEMENT L.P. holds 1.5M shares of RLMD (RELMADA THERAPEUTICS INC), worth $10.5M as of 2026-Q2. The position was increased (+502.4% shares). RLMD represents 0.0% of BALYASNY ASSET MANAGEMENT L.P.'s portfolio.

Current Value

$10.5M

Current Shares

1.5M

Total Value Change

+$6M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.5M
+502.4%
$10.5M0.0%$6.92
45
2026-Q1
Decreased
252,457
-53.9%
$1.8M0.0%$4.67
0
2025-Q4
New
547,854
-
$2.6M0.0%$4.53
36
2024-Q2
Exited
0
-100.0%
$00.0%$3.00
0
2024-Q1
New
12,322
-
$57,2970.0%$4.65
29
2022-Q4
Exited
0
-100.0%
$00.0%$3.49
0
2022-Q3
Increased
307,314
+28.8%
$11.4M0.0%$36.19
35
2022-Q2
New
238,521
-
$4.5M0.0%$19.34
37

Other major holders of RLMD: RTW INVESTMENTS, LP, Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used